Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Senhwa Announces IND Submissions for Silmitasertib for COVID-19

americanpharmaceuticalreviewNovember 12, 2020

Tag: Senhwa Biosciences , COVID-19 , Silmitasertib

PharmaSources Customer Service